Rockwell Medical Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 90.7% | 87.0% | 86.5% | 82.4% | 78.0% | 85.3% | 83.9% | 84.4% | 85.7% | 78.9% | 83.3% | 81.8% | 82.3% | |
| 9.3% | 13.0% | 13.5% | 17.6% | 22.0% | 14.7% | 16.1% | 15.6% | 14.3% | 21.1% | 16.7% | 18.2% | 17.7% | |
| 2.1% | 0.8% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.2% | – | |
| 12.2% | 12.3% | 16.7% | 13.4% | 12.6% | 13.4% | 19.5% | 20.4% | 20.9% | 20.4% | 22.0% | 20.7% | 21.0% | |
| 16.6% | 15.5% | 19.4% | 15.6% | 15.2% | 16.8% | 23.3% | 24.0% | 24.2% | 23.3% | 25.2% | 24.2% | 24.2% | |
| -7.3% | -2.5% | -5.8% | 2.0% | 6.8% | -2.1% | -7.2% | -8.4% | -9.9% | -2.2% | -8.5% | -6.0% | -6.5% | |
| 1.7% | 5.0% | 1.9% | 0.9% | 1.1% | 1.2% | 1.5% | 1.7% | 1.8% | 1.6% | 1.6% | 1.6% | 1.6% | |
| -7.9% | -6.8% | -7.6% | 1.3% | 5.9% | -3.1% | -8.0% | -9.3% | -11.0% | -3.0% | -9.3% | -6.6% | -7.3% | |
| -2.4% | -0.9% | -2.4% | 0.2% | – | – | – | – | – | – | – | – | – | |
| -7.9% | -6.8% | -7.6% | 1.3% | 5.9% | -3.1% | -8.0% | -9.3% | -11.0% | -3.0% | -9.3% | -6.6% | -7.3% | |
| -3.8% | 0.7% | -3.3% | 4.4% | 8.9% | 0.3% | -3.7% | -4.1% | -5.8% | 1.5% | -4.7% | -2.2% | -2.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.